Immunostaining and quantification of intracellular accessible cholesterol using ALOD4-mNeon in Human Fibroblasts - Aligning Science Across Parkinson's

Research Community
Research Community

ASAP supports three programs and serves as a member of multiple consortia to advance research for the benefit of the global Parkinson’s disease community.
Explore
Highlights
Highlights

ASAP shares the impact that our initiative, network, and supported programs have had on providing new insights into Parkinson’s disease. Discover news, interviews, awards, and annual impact.
Explore
Open Science
Open Science

ASAP is dedicated to facilitating a research environment where meaningful collaboration, research-enabling resources, and data sharing provides the answers we need to understand, diagnose, and treat Parkinson’s disease. Discover our open science philosophy.
Explore
Tools & Resources
Tools & Resources

ASAP is committed to developing and openly sharing research outputs, including data, code, protocols, and key lab materials, to help the scientific community build upon existing work.
Explore

Description

Here we present a protocol for quantitative immunostaining of intracellular accessible cholesterol using ALOD4-mNeon in human fibroblasts.

Identifier (DOI)

10.17504/protocols.io.rm7vzj5prlx1/v1

Tags

Cholesterol

Team

Team Alessi

Program

Collaborative Research Network

Theme

PD Functional Genomics

Meet the Authors

Sreeja Nair, PhD

Key Personnel: Team Alessi,

Stanford Medicine
Ebsy Jaimon, PhD

Key Personnel: Team Alessi,

Stanford Medicine
Suzanne Pfeffer, PhD

Co-PI (Core Leadership): Team Alessi,

Stanford University